These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

69 related items for PubMed ID: 4691882

  • 1. 6-Ureido derivatives of 9-( -D-ribofuranosyl)purine as inhibitors of adenosine kinase.
    Divekar AY, Hakala MT, Chheda GB, Hong CI.
    Biochem Pharmacol; 1973 Feb 15; 22(4):545-8. PubMed ID: 4691882
    [No Abstract] [Full Text] [Related]

  • 2. Inhibitors of adenosine kinase.
    Caldwell IC, Henderson JF.
    Cancer Chemother Rep 2; 1971 Apr 15; 2(1):237-46. PubMed ID: 5565537
    [No Abstract] [Full Text] [Related]

  • 3. Purine derivatives as competitive inhibitors of human erythrocyte membrane phosphatidylinositol 4-kinase.
    Young RC, Jones M, Milliner KJ, Rana KK, Ward JG.
    J Med Chem; 1990 Aug 15; 33(8):2073-80. PubMed ID: 2165159
    [Abstract] [Full Text] [Related]

  • 4. Identification and isolation on a large scale of guanylate kinase from human erythrocytes. Effects of monophosphate nucleotides of purine analogs.
    Agarwal RP, Scholar EM, Agarwal KC, Parks RE.
    Biochem Pharmacol; 1971 Jul 15; 20(7):1341-54. PubMed ID: 5163075
    [No Abstract] [Full Text] [Related]

  • 5. Effect of 2-aminopurine and 2-aminopurine 2'-deoxyriboside on nucleic acid synthesis in Ehrlich ascites cells in vitro.
    Frederiksen S.
    Biochem Pharmacol; 1965 May 15; 14(5):651-60. PubMed ID: 5891460
    [No Abstract] [Full Text] [Related]

  • 6. Adenosine kinase of sarcoma 180 cells N 6 -substituted adenosines as substrates and inhibitors.
    Divekar AY, Hakala MT.
    Mol Pharmacol; 1971 Nov 15; 7(6):663-73. PubMed ID: 5169930
    [No Abstract] [Full Text] [Related]

  • 7. Inhibition of the protein kinase by adenine compounds: competitive inhibition with respect to ATP.
    Iwai H, Inamasu M, Takeyama S.
    Biochem Biophys Res Commun; 1972 Jan 31; 46(2):824-30. PubMed ID: 4333428
    [No Abstract] [Full Text] [Related]

  • 8. Metabolism of phosphoramidates. IV. A phosphoryl transfer dependent on purine nucleosides.
    Khandwala PK, Smith RA.
    Biochim Biophys Acta; 1967 Apr 25; 136(3):448-58. PubMed ID: 6048262
    [No Abstract] [Full Text] [Related]

  • 9. New nucleoside analogs from 2-amino-9-(beta-D-ribofuranosyl)purine.
    Virta P, Holmström T, Roslund MU, Mattjus P, Kronberg L, Sjöholm R.
    Org Biomol Chem; 2004 Mar 21; 2(6):821-7. PubMed ID: 15007409
    [Abstract] [Full Text] [Related]

  • 10. Elucidation of aberrant purine metabolism: application to hypoxanthine-guanine phosphoribosylstransferase- and adenosine kinase-deficient mutants, and IMP dehydrogenase- and adenosine deaminase-inhibited human lymphoblasts.
    Snyder FF, Trafzer RJ, Hershfield MS, Seegmiller JE.
    Biochim Biophys Acta; 1980 Oct 17; 609(3):492-501. PubMed ID: 6108130
    [Abstract] [Full Text] [Related]

  • 11. Study of the cytotoxicity and metabolism of 4-amino-3-carboxamido-1-(beta-D-ribofuranosyl)pyrazolo[3,4-d]pyrimidine using inhibitors of adenosine kinase and adenosine deaminase.
    Wotring LL, Townsend LB.
    Cancer Res; 1979 Aug 17; 39(8):3018-23. PubMed ID: 222442
    [Abstract] [Full Text] [Related]

  • 12. Resistance to 4-aminopyrazolo (3,4-d) pyrimidine.
    Bennett LL, Allan PW, Smithers D, Vail MH.
    Biochem Pharmacol; 1969 Apr 17; 18(4):725-40. PubMed ID: 5788516
    [No Abstract] [Full Text] [Related]

  • 13. Deamination of purine antibiotics by adenosine deaminase.
    Fukagawa Y, Sawa T, Takeuchi T, Umezawa H.
    J Antibiot (Tokyo); 1965 Jul 17; 18(4):191. PubMed ID: 5898336
    [No Abstract] [Full Text] [Related]

  • 14. Synthesis of 9-(2-deoxy-beta-D-ribofuranosyl)purine-2-thione.
    Rappaport HP.
    Nucleosides Nucleotides Nucleic Acids; 2000 Apr 17; 19(4):839-43. PubMed ID: 10960040
    [Abstract] [Full Text] [Related]

  • 15. 6-Methylpurine derived sugar modified nucleosides: Synthesis and in vivo antitumor activity in D54 tumor expressing M64V-Escherichia coli purine nucleoside phosphorylase.
    Hassan AEA, Abou-Elkhair RAI, Parker WB, Allan PW, Secrist JA.
    Eur J Med Chem; 2016 Jan 27; 108():616-622. PubMed ID: 26724729
    [Abstract] [Full Text] [Related]

  • 16. Cell cycle variation in cyclic adenosine 3',5'-monophosphate-dependent inhibition of protein kinase from Physarum polycephalum.
    Kuehn GD.
    Biochem Biophys Res Commun; 1972 Oct 17; 49(2):414-9. PubMed ID: 4344888
    [No Abstract] [Full Text] [Related]

  • 17. The effect of adenosine N1-oxide on the incorporation of radioactive precursors into the nucleic acids.
    Frederiksen S, Jorgensen AO, Rasmussen AH, Tonnesen T.
    Mol Pharmacol; 1968 Jul 17; 4(4):358-66. PubMed ID: 5690986
    [No Abstract] [Full Text] [Related]

  • 18. Purine ribonucleoside kinase activity and resistance to some analogs of adenosine.
    Bennett LL, Schnebli HP, Vail MH, Allan PW, Montgomery JA.
    Mol Pharmacol; 1966 Sep 17; 2(5):432-43. PubMed ID: 5970690
    [No Abstract] [Full Text] [Related]

  • 19. Purine nucleoside inhibitors of purine biosynthesis de novo.
    Henderson JF.
    Cancer Chemother Rep 2; 1968 Nov 17; 1(2):375-82. PubMed ID: 5212263
    [No Abstract] [Full Text] [Related]

  • 20. Novel modified purine bases and nucleosides: new methodologies of synthesis and biological activity.
    Hocek M.
    Nucleic Acids Symp Ser (Oxf); 2005 Nov 17; (49):29-30. PubMed ID: 17150617
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.